Clinical and research markers of oxidative stress in chronic kidney disease (Q38075905)

28 August 2017

1 reference

title

Clinical and research markers of oxidative stress in chronic kidney disease (English)

1 reference

28 August 2017

Patrick Steven Tucker

1

1 reference

28 August 2017

Vincent James Dalbo

2

1 reference

28 August 2017

Thin Han

3

1 reference

28 August 2017

Michael Ian Kingsley

4

1 reference

28 August 2017

23 January 2013

1 reference

28 August 2017

1 reference

28 August 2017

18

1 reference

28 August 2017

103-115

1 reference

28 August 2017

2

1 reference

Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade

28 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Obesity and disease management: effects of weight loss on comorbid conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Principal component analysis of some oxidative stress parameters and their relationships in hemodialytic and transplanted patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Methods for testing antioxidant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Homocysteine, malondialdehyde and endothelial markers in dialysis patients during low-dose folinic acid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

The effects of trimetazidine on lipid peroxidation in patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

The enigma of in vivo oxidative stress assessment: isoprostanes as an emerging target.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Analysis of urinary microRNAs in chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Protein oxidation in aging, disease, and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Do different dialytic techniques have different atherosclerotic and antioxidant activities?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Postoperative acute kidney injury is associated with hemoglobinemia and an enhanced oxidative stress response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Effects of omega-3 polyunsaturated fatty-acid supplementation on redox status in chronic renal failure patients with dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Relationship between stage of kidney disease and incident heart failure in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Thioredoxin: friend or foe in human disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Oxidatively generated base damage to cellular DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Evaluation of reference values for erythrocyte glutathione.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Effects of alpha-lipoic acid on the plasma levels of asymmetric dimethylarginine in diabetic end-stage renal disease patients on hemodialysis: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

The comet assay for DNA damage and repair: principles, applications, and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Oxidative DNA damage: mechanisms, mutation, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Protein carbonylation in human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Protein carbonyl groups as biomarkers of oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Oxidants and antioxidants in long-term haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Effects of L-carnitine on oxidative stress responses in patients with renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Renovascular protective effects of erythropoietin in patients with chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Use of vitamin D in chronic kidney disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Levels of asymmetric dimethylarginine, nitric oxide and lipid peroxidation markers in patients with end-stage renal disease having peritoneal dialysis treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Paraoxonase 1 in chronic kidney failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

The measurement and mechanism of lipid peroxidation in biological systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

21 January 2018

Glutathione transferases

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Catalase deficiency accelerates diabetic renal injury through peroxisomal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Homocysteine is a protein amino acid in humans. Implications for homocysteine-linked disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Tocotrienols from palm oil as effective inhibitors of protein oxidation and lipid peroxidation in rat liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Increased level of advanced oxidation protein products in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Glutathione and riboflavin status in supplemented patients undergoing home nocturnal hemodialysis versus standard hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Assessment of matrix Gla protein, Klotho gene polymorphisms, and oxidative stress in chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Asymmetric dimethylarginine: a novel marker of risk and a potential target for therapy in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Increased glomerular and extracellular malondialdehyde levels in patients and rats with focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Measurement of F2-isoprostanes, hydroxyeicosatetraenoic products, and oxysterols from a single plasma sample

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Oxidative stress and inflammation in renal patients and healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Cholesteryl ester oxidation products in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Free radicals, antioxidants and functional foods: Impact on human health

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Oxidative stress in end-stage renal disease: an emerging threat to patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

SOD, oxidative stress and human pathologies: a brief history and a future vision.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Mediterranean diet improves dyslipidemia and biomarkers in chronic renal failure patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Effect of selenium supplementation on biochemical markers and outcome in critically ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Postprandial metabolic response to a fat- and carbohydrate-rich meal in patients with chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Hydrolytic elimination of a mutagenic nucleotide, 8-oxodGTP, by human 18-kilodalton protein: sanitization of nucleotide pool

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Assessment of reference values for DNA damage detected by the comet assay in human blood cell DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Biocompatibility of heparin-grafted hemodialysis membranes: impact on monocyte chemoattractant protein-1 circulating level and oxidative status

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Ezetimibe decreases serum levels of asymmetric dimethylarginine (ADMA) and ameliorates renal injury in non-diabetic chronic kidney disease patients in a cholesterol-independent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Co-administration of ezetimibe enhances proteinuria-lowering effects of pitavastatin in chronic kidney disease patients partly via a cholesterol-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: results from the Ant

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Effect of oral N-acetylcysteine treatment on plasma inflammatory and oxidative stress markers in peritoneal dialysis patients: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Lipid peroxidation: physiological levels and dual biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Multiple-dose pharmacokinetics and pharmacodynamics of N-acetylcysteine in patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Role of oxidative stress in age-associated chronic kidney pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Bardoxolone methyl and kidney function in CKD with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Homocysteine and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Oxy-radicals and related species: their formation, lifetimes, and reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Oxidative stress in non-insulin-dependent diabetes mellitus (NIDDM) patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Lipoperoxidation and hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Evaluation of oxidative stress biomarkers in patients with chronic renal failure: a case control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Interrelationship between uremic toxicity and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Coenzyme Q10 administration suppresses both oxidative and antioxidative markers in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Impact of vitamin E on plasma asymmetric dimethylarginine (ADMA) in chronic kidney disease (CKD): a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stage renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

A novel HPLC method for the measurement of thiobarbituric acid reactive substances (TBARS). A comparison with a commercially available kit.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Erythrocyte antioxidant defense system in patients with chronic renal failure according to the hemodialysis conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

ADMA and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Effect of vitamin E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA of hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Protective effect of vitamin C on 8-hydroxy-2'-deoxyguanosine level in peripheral blood lymphocytes of chronic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Reduction of oxidative stress augments natriuretic effect of furosemide in moderate heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

The importance of glutathione in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Serum C-reactive protein and thioredoxin levels in subjects with mildly reduced glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

8-hydroxy-2' -deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Assessment of oxidative stress in the early posttransplant period: comparison of cyclosporine A and tacrolimus-based regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Miles to go before we sleep: racial inequities in health

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Intradialytic exercise training reduces oxidative stress and epicardial fat: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Protein carbonyl levels, glutathione S-transferase polymorphisms and risk of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

The effect of selenium supplementation in the prevention of DNA damage in white blood cells of hemodialyzed patients: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Liquid chromatographic determination of total homocysteine in blood plasma with photometric detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Lipid Peroxidation and Antioxidant Enzymes in CAPD Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

Quantification of F2-isoprostanes as a biomarker of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2012.749302

10.3109/1354750X.2012.749302

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference